SPL 1.05% 9.6¢ starpharma holdings limited

Except that Staroharma have a strong history of failing to...

  1. 92 Posts.
    lightbulb Created with Sketch. 22
    Except that Staroharma have a strong history of failing to commercialize their products, of over promising and under delivering and of failing to do due diligence sufficiently well. They may be good scientists who are well remunerated themselves, but they have a terrible business track record to date. I know everyone keeps talking about the DEP products, but going on past experience, they will stuff up getting those to market also, and the timelines will have blown out by years. I have no faith left. I will sell when I need the money.
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.